Tags:DevelopmentManufacturingPublic
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. Acceleron went public in September 2013 (NASDAQ: XLRN).
Location: United States, Cambridge
Total raised: $30M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
23.12.2011-$30M-Acceleron ...

Mentions in press and media 8

DateTitleDescriptionCategoryAuthorSource
29.03.2019Shares of bluebird on the Nasd...--medcitynew...
20.03.2019Flagship P...“With each year of company o...--medcitynew...
26.03.2015Flagship V...The company’s previous fund ...--medcitynew...
01.11.2013OrbiMed cl...Looking back 5 to 6 years, hea...--medcitynew...
20.01.2012Boston’s...Share Share on Facebook Share ...-Gregory T....xconomy.co...
23.12.2011Acceleron ...Acceleron Pharma, Inc., a Camb...funding U...-finsmes.co...
30.10.2007Life scien...Featured companies: Acceleron ...--venturebea...
19.09.2007Life scien...Featured companies: Acceleron ...--venturebea...